Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations

Eitemau Tebyg

• High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
  gan: Kraan, W, et al.
  Cyhoeddwyd: (2013)
• Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
  gan: Visco, Carlo, et al.
  Cyhoeddwyd: (2020)
• CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
  gan: Trøen, Gunhild, et al.
  Cyhoeddwyd: (2013)
• Oncogenically active MYD88 mutations in human lymphoma
  gan: Ngo, Vu N., et al.
  Cyhoeddwyd: (2010)
• MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
  gan: de Groen, Ruben A.L., et al.
  Cyhoeddwyd: (2019)